#226 | Why Your MedTech Product May Be Ready to Launch But Not Ready to Sell

Your medical device has regulatory approval, clinical evidence and manufacturing in place but does that actually mean customers are ready to buy it?This doesn't diagnose their problem. It challenges the assumption that the three green ticks automatically equal commercial readiness.A MedTech product can be completely ready to launch and still not be commercially ready to sell. Before spending heavily on salespeople, distributors, exhibitions or new export markets, you need to know whether customers have genuine demand, how your medical device actually gets bought, and what could make adoption harder than expected. In this episode, Hakeem explains how to assess your commercial readiness before scaling a go-to-market strategy that may not yet work.In this episode you'll discover:How to distinguish genuine customer demand from positive feedback and interest before investing heavily in commercialisation.Why understanding the complete buying pathway—from clinicians and other decision-makers to evidence, procurement and budgets—is critical to turning interest into revenue.How to identify adoption friction and stress-test your go-to-market model before adding more salespeople, distributors or export markets.Listen now to discover whether your MedTech product is genuinely ready to sell—and what you need to fix before investing more money in commercialisation, adoption and international growth.Message me via DM on LinkedinTake the CPI Quiz to see how commercially ready your product isThis podcast is for clinicians feeling stuck in turning medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, and to scale up their international sales in MedTech.